2024-03-26

Glad tidings丨ZSHK Laboratories Limited was selected into “Hong Kong Life Sciences Story 2024”

The Hong Kong Bio-Med Innotech Association successfully hosted the Hong Kong Life Science Story 2024 pressconference on March 14, 2024. The sole preclinical CRO business among the ones chosen for the Hong Kong Life Science Story 2024 is ZSHK...

Read more +

2023-12-29

Highlights Review | Summary of ZSHK's Activities in the Second Half of 2023

July 20th, Dr. Li Ming, CEO of ZSHK, was elected as the vice chairman of the third Innovation the Third Innovation and RD Service Committee of PhIRDA. He also proposed constructive suggestions for the future work plan and development directi...

Read more +

2023-12-06

Invitation | Anling Biomed (Shenzhen) looks forward to meeting with you at 2023 InnoXBio

The 2023 Inno X Bio will be held at the Convention And Exhibition Center of China-Singapore Guangzhou Knowledge City in the Huangpu District of Guangzhou, Guangdong from December 7th to 8th, 2023. Anling Biomed (Shenzhen) Co. Ltd., a subsidi...

Read more +

2023-12-02

Anling Biomed (Shenzhen) attended the 2023 Annual Meeting of Pharmacology and Toxicology

In 29 November to 2 December 2023, ZSHK Laboratories Limited. (hereinafter referred to as ZSHK) wholly-owned subsidiary, Anling Biomed (Shenzhen) Co., Ltd. (hereinafter referred to as Anling (Shenzhen)), was invited to attend the 2023 Annual...

Read more +

2023-11-27

Good news丨  Anling Biomed (Suzhou) Co., Ltd. has been recognized as a national high-tech enterprise.

In November 2023, Anling Biomed (Suzhou) Co., Ltd. officially obtained the certification as a national high-tech enterprise, which is a high recognition of the companys continuous innovation and technological development, as well as an activ...

Read more +